glp 1 gip triple agonist The Road towards Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor Hitting the Triple G Spot:

"We welcome research that seeks to better understand patients perspectives

Unlike the simple sugars glucose and fructose, allulose is not metabolized by the body, and doesn't contribute to elevated postprandial blood glucose levels

Leaving aside their newly approved use for obesity, accelerated growth in the utilization of GLP-1s for diabetes had already made them a top trend driver over the past few years

The obesity epidemic affecting our youth requires innovative approaches, and GLP-1 RAs may represent an important advancement in our therapeutic armamentarium

doi: 10.1016/j.ejphar.2012.12.012 [DOI] [PubMed] [Google Scholar] 132